Literature DB >> 20107694

E-procurement in the Brazilian healthcare system: the impact of joint drug purchases by a hospital network.

Fernando Sigulem1, Paola Zucchi.   

Abstract

OBJECTIVE: To evaluate the use of e-procurement to obtain supplies for a network of seven university hospitals with a joint purchase system.
METHODS: The study was carried out between October 2003 and October 2005. We analyzed nine joint purchases of 37 pharmaceutical items. All the items were purchased in at least two-thirds of the nine occasions and/or were among the 10 items with the highest expenditure. The following aspects were recorded: price, number of suppliers providing quotes, type of supplier (distributor or manufacturer), reference value (lowest price paid per item by each hospital prior to the establishment of the joint purchase system), unit price for first purchase, and unit price for last purchase. The percent variation in price was compared in relation to the reference value, first and last purchases, and average unit price for the nine purchases.
RESULTS: A decrease in price > 10% was observed in 47% of the medications analyzed. A decrease > 20% was recorded in 32% of the 37 items. Five items (midazolam 5 mg 3 mL, tramadol 100 mg 2 mL, vancocin 500 mg vial, ceftazidime 1 g vial and cefepime 1 g vial) had a decrease >or= 50% in unit cost in the first purchase compared to the last purchase value. The unit price for 26 items (70%) had an average reduction of 23%.
CONCLUSIONS: E-procurement was successful in achieving real savings. The results show that the incorporation of new management technologies such as e-procurement in the healthcare setting may help overcome the management gap in the healthcare sector.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20107694

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  4 in total

1.  Centralised Pharmaceutical Procurement: Learnings from Six European Countries.

Authors:  Sabine Vogler; Eveli Bauer; Katharina Habimana
Journal:  Appl Health Econ Health Policy       Date:  2022-05-06       Impact factor: 3.686

2.  Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries.

Authors:  Gabriel Seidman; Rifat Atun
Journal:  BMJ Glob Health       Date:  2017-04-13

3.  Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series.

Authors:  Hongfei Long; Ying Yang; Xin Geng; Zongfu Mao; Zhenhua Mao
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

4.  An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.

Authors:  Tim K Mackey; Raphael E Cuomo
Journal:  Glob Health Action       Date:  2020       Impact factor: 2.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.